IL27 and neoplasm: The data again indicated a decreased cytotoxicity of IL-27Ra KO NK cells toward PyMT tumor cells and, more importantly, revealed an enhanced cytotoxicity of WT NK cells, but not IL-27Ra KO NK cells, when supplemented with recombinant IL-27 (Figure 6B).